⌘K

Login Start Free

Home/Filings/4/0000899243-20-004301

4//SEC Filing

GARDNER JASON 4

Accession 0000899243-20-004301

CIK 0001690585other

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 5:07 PM ET

Size

5.4 KB

Accession

0000899243-20-004301

Insider Transaction Report

Form 4

Period: 2020-02-10

Magenta Therapeutics, Inc.MGTA

DirectorSee Remarks

Transactions

Award
Stock Option (Right to Buy)
2020-02-10+275,000→ 275,000 total
Exercise: $12.28Exp: 2030-02-09→ Common Stock (275,000 underlying)

Footnotes (1)

[F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on January 1, 2020.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Magenta Therapeutics, Inc.

CIK 0001690585

Entity typeother

Related Parties

1

filerCIK 0001741286

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 5:07 PM ET
Size: 5.4 KB

View on SEC.gov